Imidazolinone ring system is of biological and chemical interest since long. The imidazolinones [1] are associated with a wide range of therapeutic activities [2] [3] [4] [5] [6] [7] such as anticonvulsant, sedative and hypnotic, potent CNS depressant, antihistamine, antifilarial, bactericidal, fungicidal, antiinflammatory, MAO inhibitory, antiparkinsonian, antihypertensive and anthelmintic. Recently some new imidazolinone derivatives have been reported as antiinflammatory, herbicidal and hypertensive activities. Some workers have recognized 5-imidazolone as having anticancer activity [8] . The therapeutic importance of the compounds inspired us to synthesize some potential imidazolinones [9] [10] [11] [12] [13] .
Desai et al. [14] have synthesized 4-benzylidene-2-phenyloxazole-5-one based on the methods descried in the literature which is a special type of Perkin condensation in which reaction between aldehyde and benzoylglycine proceeds first followed by ring closer. It is observed that aldehyde condenses under the influence of a base with the reactive methylene group in the azalactone which is formed by the dehydration of benzoylglycine, when the latter reacts with Ac 2 O in presence of sodium acetate. In view of these observations, we have synthesized imidazol-5-ones (Scheme I, Table 1 ). Melting points were taken in open capillaries using paraffin bath and are uncorrected. IR spectra were recorded on FTIR-Perkin-Elmer spectrometer (V max cm -1 ); 1 H NMR spectra were recorded on Bruker Avance 300 FT-NMR spectrometer using CDCl 3 as a solvent and mass spectra carried out on JEOL SX 102/DA-600 mass spectrometer, respectively. All the compounds were analyzed for carbon, hydrogen and nitrogen and the results were within ±0.4% of theoretical values. Purity was checked by TLC using TLC aluminum sheets silica gel 60, supplied by E. Merck, Mumbai, India. The spots were located by keeping the plates in iodine vapor and 2,4,5-trichlorobenzenamine was supplied by S. D. Fine Chem Limited, Mumbai, India. 4-Chlorobenzohydrazide, 2,4-dichlorobenzo hydrazide and 4-arylidene-2-phenyloxazol-5(4H)-one (3a-q), were prepared as given in literature method [15] [16] [17] [18] [19] [20] .
4-Arylidene-2-phenyl-1-(2,4,5-trichlorophenyl)-1H-imidazol-5(4H)-one (4) were synthesized as follows; A mixture of 2,4,5-trichloroaniline (0.01 mol) and 4-(arylidene)-2-phenyloxazol-5(4H)-ones (0.01 mol) was placed in a round bottom flask and 10 ml of pyridine were added to it. The reaction mixture was refluxed on a sand bath for 6 h. (scheme I) and the mixture was poured into ice-cold water and then a required amount of conc. hydrochloric acid was added to neutralize the reaction mixture. The progress of the reaction and the purity of compounds were routinely checked on TLC. ) . Other compounds of the series were prepared by using a similar method and their physical data are recorded in Table 1 . benzylidene-5-oxo-2-phenyl-4,5-dihydroimidazol-1-yl)-2,4-dichlorobenzamides (6) were prepared using the following procedure; A mixture of 4-chlorobenzohydrazide/ 2,4-dichlorobenzohydrazide (0.01 mol) and 4-(arylidene)-2-phenyloxazol-5(4H)-ones (0.01 mol) was placed in a round bottom flask and 10 ml of pyridine was added to this mixture. The reaction mixture was refluxed on a sand bath for 6 h (Scheme I). The mixture was poured into ice-cold water and then required amount of con. hydrochloric acid was added to neutralize the reaction mixture. The solid obtained was left overnight, filtered and washed with water. The product was dried and recrystallized from ethanol (99%).
Compound 5f: IR (KBr): 3249 cm -1 (medium -CONH-), 3033 cm -1 (-C-H str., aromatic), 1656 cm -1 (>C=O str., cyclic ring), 1625 cm -1 (>C=N str., imidazol ring), 1490 cm -1 ( >NH weak), 1299 cm -1 (-C-N tertiary amine), 1095 cm -1 (-C-Cl str., aromatic), 754 cm -1 (>C=CH medium ), 707 cm Compound 6e: IR (KBr): 3213 cm -1 (medium, -CONH-), 2993 cm -1 (-C-H str., aromatic), 1662 cm -1 (>C=O str., cyclic ring), 1635 cm -1 (>C=N str., imidazol ring), 1473 cm -1 (>NH weak), 1305 cm -1 (-C-N tertiary amine), 1109 cm -1 (-CCl str., aromatic), 925 cm -1 (>C=CH medium), 825, 713 cm -1 (disubstituted aromatic), 707 cm -1
(monosubstituted aromatic). 1 H NMR (CDCl 3 ): δ7.2 (s, 1H ,-CH), 7.32-8.05 (m, 12H, Ar-H,C=C-Ar), 10.02 (s,1H, -NH-CO-) ppm. MS: m/z 471 with 79% relative intensity (base peak) and 472 with 51% relative intensity (M + ). Other compounds of the series were prepared by using a similar method and their physical data are recorded in Table 1 .
Antibacterial activity was carried out by broth dilution method [21] . The strains used for the activity were procured from Institute of Microbial Technology, Chandigarh. The compounds 4a-q, 5a-o and 6a-m were screened for their antibacterial activity against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Staphylococcous pyogenes at concentrations of 1000, 500, 200, 100, 50, 25, 12.5 µg/ml respectively ( Table 2 ). Same compounds were tested for antifungal activity against C. albicans, A. niger and A. clavatus at concentrations of 1000, 500, 200, and 100 µg/ml respectively ( Table 2 ). The results are recorded in the form of primary and secondary screening.
The synthesized compounds found to be active in the primary screening were further tested in a second set of dilution against all microorganisms. The compounds found active in primary screening were similarly diluted to obtain 100, 50, 25 μg/ml concentrations. Ten microlitres suspensions from each well were further inoculated on appropriate media and growth was noted after 24 and 48 h. The lowest concentration, which showed no growth after spot subculture was considered as MBC/MFC for each drug. The highest dilution showing at least 99% inhibition was taken as MBC/MFC. The result 4a  25  ------4b  25  50  -----4f  100  ---100  100  100  4i  25  ------4j  25  ------4k  50  100  50  ----4q  50  100  -----5b  ----100  100  100  5e  50  50  -----6f  100  ---100  100  100  6j  ------100  6l  ----100  -100  6m  ----100 --Gentamycin is used as standard for antibacterial activity which showed (0.05, 0.25, 0.5 and 1 μg/ml) MBC against E. coli, S. aureus, S. pyogenus and P. aeruginosa respectively. K nystatin was used as the standard for antifungal activity which showed 100 µg/ml MFC against fungi, used for the antifungal activity. *All the compounds were tested for the antibacterial and antifungal activities but data of active compounds have been reported as present protocol of this test is affected by the size of the inoculums. The test mixture should contain 10 8 organisms/ml. For antibacterial activity, in present protocol 50 µg/ml is considered as active as compared to the standard drug gentamycin. For antifungal activity, 100 µg/ml is considered as active as compared to standard nystatin. Compounds 4a, 4b, 4i, 4j, 4k, 4q and 5e are active on E. coli where as 4b and 5e are active on P. aeruginosa. Compound 4k is active on S. aureus and 6m is also active on S. pyogens. Compounds 4f, 5b, 6f, 6l, and 6m are active on fungi strains. On the basis of biological activity results, it may be concluded that the introduction of OH, OCH 3 , NO 2 , Cl and Br groups to the heterocyclic frame work enhanced antibacterial and antifungal activities.
